ESHI Educational Webinars 2017


ESHI Webinars Schedule 2017

In a series of online lectures, distinguished experts in the field of hybrid imaging will share their knowledge about various modalities and subspecialties related to the fusion of nuclear medicine and radiology as well as molecular imaging.

The first five webinars will be free to join for everybody, whereas the last four will only be free for ESHI members. Moreover, the lectures will be uploaded into the MyUserArea, so every active member can enjoy and rewatch the lectures at their own convenience.



Webinar 6


Date: September 20, 2017
Time: 17:00 (CEST)
Speaker: Thomas Beyer, PhD (Vienna/AT)
Registration: Click here!


More information will be coming soon!


Webinar 7


Date: October 25, 2017
Time: 17:00 (CEST)
Speaker: Prof. Dr. Mathias Gutberlet (Leipzig/DE)
Registration: Click here!


Webinar 8


Date: November 22, 2017
Time: 17:00 (CET)
Speaker: Prof. Dr. Jürgen Schäfer (Tübingen/DE)
Registration: Click here!


Webinar 9


Date: December 20, 2017
Time: 17:00 (CET)
Speaker: Thomas Beyer, PhD (Vienna, Austria)
Registration: Click here!





Date: February 22, 2017
Time: 17:00 (CET)
Speaker: Thomas Beyer, PhD (Vienna, Austria)

The past decade has been a decade of hybrid imaging. Hybrid imaging comprises hardware combinations of complementary anatomical and molecular imaging methods. These include SPECT/CT, PET/CT and PET/MR, with other options being discussed and explored.

This webinar is on the basics of hybrid clinical imaging today. The tutor is Thomas Beyer, PhD, a co-developer of PET/CT. He will briefly explain the origins of hybrid imaging (SPECT/CT, PET/CT and PET/MR) before highlighting the basic methodologies associated with these imaging technologies. The webinar will include an update on applications and challenges before ending with an outlook. The key take home message is “Moving machineries closer together, requires to do the same with people and expertises”.

Learning Objectives:

  1. To review the origins of SPECT/CT, PET/CT and PET/MR imaging systems.
  2. To understand the basic principles and general clinical applications.
  3. To speculate on trends in dual-modality PET- and SPECT-based imaging technology.

About the Speaker

Beyer_201607Thomas Beyer holds a PhD in Physics and is co-developer of the first combined PET/CT system worldwide. He has a background in research and project management in academia and imaging industry.

Thomas graduated in Physics at the Leipzig University (Germany) and got his PhD in Medical Physics from Surrey University (UK). During his US-based studies he became involved in the development and clinical testing of the first PET/CT prototype (1992-2000) before joining Siemens/CTI PET Systems as an International PET/CT specialist.

In 2002 he became a Research Associate in Nuclear Medicine and Radiology and PET/CT project manager at Essen University Hospital (Germany). In 2006 he became Teaching Professor (Priv-Doz) for Experimental Nuclear Medicine at Essen, and joined timaq medical imaging Inc, a Zurich-based Imaging CRO. In 2007 he moved to Philips Medical Systems as International Manager Clinical Science Nuclear Medicine. In 2008 he set up a Zurich-based consulting company for expert advise in cross-modality imaging and applications. He is appointed full professor of Physics of Medical Imaging at the Medical University of Vienna from March 2013.

Thomas is a member of various national and international Medicine organizations, a founding member of the European Association of Nuclear Medicine (EANM) Physics Committee and past Head of the New Technology working group at the Association of Imaging Producers and Equipment Suppliers (AIPES). He is a co-founder of the European Society of Hybrid Imaging and a Board M


Date: March 29, 2017
Time: 17:00 (CET)
Speaker: Osman Ratib MD, PhD (Geneva/CH)



Hybrid imaging brings more to clinical practice and patient management than simple fusion of images from different imaging modalities. Since the introduction of PET-CT in clinical practice and later the extension of hybrid modalities to SPECT-CT and PET-MRI, specific applications of these modalities emerged, addressing clinical issues beyond the simple added value of better localization and diagnostic confidence of the combination of metabolic anomalies and their specific localisation in organs and tissues.

This webinar will review theses well established applications of hybrid imaging in specific clinical domains such as on oncology for breast, head and neck and prostate imaging, in neurodegenerative diseases, in assessment of musculoskeletal diseases and in cardiovascular imaging.


Learning objectives:

  1. To review the clinical applications of the different hybrid modalities
  2. To learn about the current clinical guidelines and best practices of use of hybrid imaging in clinical practice
  3. To foresee current and future developments in molecular imaging techniques and their potential impact on patient management


About the Speaker

Pic_Osman RatibProfessor Osman Ratib is dual board certified in cardiology and Nuclear Medicine and carries a PhD in Biomedical Physics in digital imaging. In July 1998 he was appointed as Professor and Vice Chairman of the Department of Radiology at University of California Los Angeles (UCLA).

He was responsible for coordinating the deployment of an enterprise-wide strategy and infrastructure for image management and communication. In July 2005 he returned to Geneva to take the position chair of the Department of Medical Imaging and Information Sciences and head of the Nuclear Medicine division. He pioneered several innovative projects in hybrid molecular imaging PET-CT and SPECT-CT and the first whole-body PET-MRI unit in Europe.

He is founder and president of the OsiriX foundation, a non-profit organization for the promotion of Open-Source software in medicine. Founder and director of the Translational Molecular Imaging Institute in Geneva, created under the joint leadership of to the University of Geneva and Technical university EPFL in Lausanne.


Date: April 26, 2017
Time: 17:00 (CEST)
Speaker: Prof. Gerald Antoch, MD (Düsseldorf/DE)



This webinar will be held as a hands-on course to guide the radiologist and nuclear medicine physician on how to use PET/CT in patients with lymphoma. This course will summarize typical findings on CT and FDG-PET, which complement one another at the time of diagnosis and tumor staging.

While morphology is important in diagnosis,  differential diagnosis, and staging, therapy response assessment is mainly based on FDG-PET. But, on which criteria do you base therapy response assessment with PET? Should you perform interim-PET or PET at the end-of-treamtent? And, how does immunotherapy affect your PET results?

Watch the webinar, and you will know!


Learning objectives:

  1. To learn about typical findings of FDG-PET/CT in lymphoma.
  2. To review international recommendations for staging and therapy response assessment in lymphoma.
  3. To communicate criteria applied for therapy response assessment with PET/CT.


About the Speaker

Pic_Gerald AntochGerald Antoch is professor of radiology and chairman of the department of diagnostic and interventional radiology at Düsseldorf University Hospital.

After completing his medical training, Dr. Antoch began working in general surgery before starting his training in diagnostic and interventional radiology at Essen University Hospital. He became a board certified radiologist in 2004. From 2004 to 2008, he worked as a consultant radiologist and became vice chairman of the department of radiology at Essen University Hospital in 2008. In 2010 he was appointed chairman of the department of diagnostic and interventional radiology at Düsseldorf University Hospital.

Prof. Antoch’s scientific research focuses on clinical hybrid imaging. He has published 209 original scientific articles and reviews, as well as 20 book chapters. He has received widespread recognition for his work with a number of awards. In 2003, he received the Alavi-Mandell Award from the Society of Nuclear Medicine, United States, and that same year he won Aunt Minnie’s Best Scientific Paper Award, which he won again in 2004. In 2005 he was awarded the Lodwick Award at Harvard Medical School followed by awards from the Bavarian Association of Nuclear Medicine and the German Cancer Research Center in the same year. In 2007 the German Radiological Society presented Prof. Antoch with the Wilhelm Conrad Röntgen Award.



Date: May 31, 2017
Time: 17:00 (CEST)
Speaker: Dr. Sergios Gatidis (Tübingen/DE)



This webinar will give an overview over the use of hybrid imaging in the diagnostic work-up of patients with head and neck cancer. Specific technical challenges and pitfalls of head and neck imaging and available solutions will be summarized. Current indications for the use of PET/CT and PET/MRI will be presented in the context of international guidelines.

In addition, comparative strengths and limitations of PET/CT and PET/MRI will be discussed in a clinical context and with respect to research applications. Potential future applications including the use of specific PET tracers will be presented.


Learning objectives:

  1. To learn about technical challenges and possible solutions in head and neck imaging.
  2. To know about international recommendations for the use of hybrid imaging in head and neck cancer.
  3. To assess strengths and limitations of PET/CT and PET/MRI for imaging of head and neck cancer.


About the speaker:

Picture_Sergios_GatidisSergios Gatidis is Radiologist at the Department of Radiology of the University Hospital in Tübingen/Germany.

He studied Medicine and Mathematics at the Eberhard-Karl-Universität Tübingen.

Currently he is responsible for the multidisciplinary PET/MRI research group in Tübingen. S. Gatidis’ focus of research lies in clinical hybrid imaging studies and the development of techniques for the analysis of multiparametric imaging data from PET/CT, MRI and PET/MRI.

Date: June 28, 2017
Time: 17:00 (CEST)
Speaker: Prof. Dr. Dr. Katrine Riklund (Umeå/SE)



The lecture will be an intoduction to the use of FDG-PET/CT in staging of lung cancer. The TNM classification system will be briefly covered and how to use FDG for metabolic staging will be discussed. Some typical FDG-PET/CT lung cancer cases will also be demonstrated.


Learning objectives:

  • To learn about TNM classification of lung cancer
  • to understand metabolic staging of lung cancer with FDG-PET/CT
  • to learn about interpretation of examination with FDG-PET/CT in lung cancer


About the speaker

Katrine Riklund, graduated at Umeå university in 1988, licensed in radiology in 1994 and in nuclear medicine in 1997. She

defended her PhD thesis about radioimmunoscintigraphy and radioimmunitherapy, in 1992, and received a position as senior lecturer in 1993.

In 2002 she was appointed as full clinical professor in diagnostic radiology at Umeå University and she still holds that position. During 2000-2002 Dr. Riklund was the head of the clinical department of Radiology at Umeå university hospital and is thereafter responsible for the department of nuclear medicine. She was deputy dean of the medical faculty 2008-2011 and is now the director of the medical school. 

Dr. Riklund started her work in science in translational research between immunology and nuclear medicine by developing and evaluation of monoclonal antibodies in the diagnosis and treatment of gynecological cancers.Thereafter hybrid imaging took her interest and imaging research in cognition, neurodegeneration and movement disorders was added. Oncologic imaging of prostate and colorectal cancer is her third area of interest.

The linker between the different areas in her research is hybrid imaging, SPECT/CT, PET/CT and PET/MR. The research also includes a focus on dopamine in imaging, both pre- and postsynaptic.

She has several commitments in radiology societies and is the past president of both the Swedish society of radiology and the Swedish society of nuclear medicine. She is the Chair of the Board of Center for medical image science and visualisation, University of Linköping, Sweden. At moment, she is immediate Past President of the European Society of Radiology and the first President of the European Society of Hybrid Medical Imaging.